Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01736059
PHASE1

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Sponsor: University of California, Davis

View on ClinicalTrials.gov

Summary

This pilot study is to determine whether it would be safe and feasible to inject CD34+ stem cells from bone marrow into the eye as treatment for patients who are irreversibly blind from various retinal conditions.

Official title: A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes With Vision Loss From Retinopathy

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2012-07

Completion Date

2026-10

Last Updated

2026-01-29

Healthy Volunteers

No

Interventions

DRUG

CD34+ bone marrow stem cells intravitreal

Locations (1)

University of California Davis

Sacramento, California, United States